| Q92588203 | A Longitudinal Study of S. aureus Infection in a National Cohort of Surgical Patients |
| Q47267604 | A Multicenter Study of Irrigation and Debridement in Total Knee Arthroplasty Periprosthetic Joint Infection: Treatment Failure Is High |
| Q61812826 | A Precautionary Approach to Guide the Use of Transition Metal-Based Nanotechnology to Prevent Orthopedic Infections |
| Q92136447 | A cost-effectiveness analysis of mupirocin and chlorhexidine gluconate for Staphylococcus aureus decolonization prior to hip and knee arthroplasty in Alberta, Canada compared to standard of care |
| Q37703145 | Acute Delayed or Late Infection of Revision Total Hip Arthroplasty Treated with Debridement/Antibiotic-loaded Cement Beads and Retention of the Prosthesis |
| Q36825836 | Acute infections after fracture repair: management with hardware in place |
| Q88405928 | Acute periprosthetic knee infection: is there still a role for DAIR? |
| Q47660761 | Adherence to standard operating procedures is crucial for intensive care unit survival of elderly patients. |
| Q37570739 | Aggressive Early Debridement in Treatment of Acute Periprosthetic Joint Infections After Hip and Knee Replacements |
| Q36293329 | Aggressive early débridement for treatment of acutely infected cemented total hip arthroplasty |
| Q38314400 | An update on surgical and antimicrobial therapy for acute periprosthetic joint infection: new challenges for the present and the future |
| Q84021713 | Antibiotic treatment can be safely stopped in asymptomatic patients with prosthetic joint infections despite persistent elevated C-reactive protein values |
| Q36952149 | Antibiotic-tolerant Staphylococcus aureus Biofilm Persists on Arthroplasty Materials |
| Q36514161 | Antimicrobial agents in orthopaedic surgery: Prophylaxis and treatment |
| Q37544629 | Antimicrobial-related severe adverse events during treatment of bone and joint infection due to methicillin-susceptible Staphylococcus aureus |
| Q36233265 | Assessing the gold standard: a review of 253 two-stage revisions for infected TKA. |
| Q34519245 | Baseline hypovitaminosis D is not associated with poor clinical outcomes in osteoarticular infections |
| Q64111893 | Benefits and Adverse Events Associated with Extended Antibiotic Use in Total Knee Arthroplasty Periprosthetic Joint Infection |
| Q33583234 | Biofilm and the Role of Antibiotics in the Treatment of Periprosthetic Hip and Knee Joint Infections |
| Q40789095 | CORR Insights(®): Cathodic Voltage-controlled Electrical Stimulation Plus Prolonged Vancomycin Reduce Bacterial Burden of a Titanium Implant-associated Infection in a Rodent Model |
| Q64114588 | Calcium Phosphate Spacers for the Local Delivery of Sitafloxacin and Rifampin to Treat Orthopedic Infections: Efficacy and Proof of Concept in a Mouse Model of Single-Stage Revision of Device-Associated Osteomyelitis |
| Q34622239 | Can Implant Retention be Recommended for Treatment of Infected TKA? |
| Q38230862 | Can periprosthetic hip joint infections be successfully managed by debridement and prosthesis retention? |
| Q34622136 | Can this prosthesis be saved?: implant salvage attempts in infected primary TKA. |
| Q42287781 | Characteristics and outcome of 16 periprosthetic shoulder joint infections. |
| Q42230743 | Characteristics and treatment outcomes of 69 cases with early prosthetic joint infections of the hip and knee |
| Q38962891 | Characteristics of prosthetic joint infections leading to bacteremia: a case-control study |
| Q92511368 | Chronic Implant-Related Bone Infections-Can Immune Modulation be a Therapeutic Strategy? |
| Q92703881 | Clinical Experience with Tigecycline in the Treatment of Prosthetic Joint Infections |
| Q47584407 | Clinical outcomes and costs among patients with Staphylococcus aureus bacteremia and orthopedic device infections |
| Q33771840 | Clinical practice. Infection associated with prosthetic joints |
| Q43962636 | Clinical spectrum and outcome of critically ill patients suffering from prosthetic joint infections |
| Q38215477 | Coatings and surface modifications imparting antimicrobial activity to orthopedic implants |
| Q42693654 | Comparison of a low-pressure and a high-pressure pulsatile lavage during débridement for orthopaedic implant infection. |
| Q36360233 | Comparison of infection control rates and clinical outcomes in culture-positive and culture-negative infected total-knee arthroplasty |
| Q36482663 | Coronary stent infections: a case report and literature review |
| Q36233240 | Culture-negative periprosthetic joint infection does not preclude infection control |
| Q50896206 | Culture-negative prosthetic joint infection. |
| Q92962537 | DAIR (Debridement, Antibiotics and Implant Retention) less effective in hematogenous total knee arthroplasty infections |
| Q90005169 | Debridement, Antibiotics and Implant Retention for Early Periprosthetic Infections of the Hip: Outcomes and Influencing Factors |
| Q90226337 | Debridement, Antibiotics, and Implant Retention for Acute Periprosthetic Joint Infection |
| Q34100226 | Determinants of methicillin-susceptible Staphylococcus aureus native bone and joint infection treatment failure: a retrospective cohort study |
| Q43785719 | Diagnosis and treatment of implant-associated septic arthritis and osteomyelitis |
| Q91828857 | Does Suture Type Influence Bacterial Retention and Biofilm Formation After Irrigation in a Mouse Model? |
| Q40516318 | Early implant-associated osteomyelitis results in a peri-implanted bacterial reservoir |
| Q36013589 | Early prosthetic joint infections treated with debridement and implant retention: 38 primary hip arthroplasties prospectively recorded and followed for median 4 years |
| Q48355587 | Efficacy and safety of rifampin containing regimen for staphylococcal prosthetic joint infections treated with debridement and retention |
| Q37147665 | Efficacy of Debridement for Early Periprosthetic Joint Infection after Hip Arthroplasty |
| Q44736605 | Endoprosthesis infections of the shoulder: diagnosis and therapy algorithm |
| Q37300225 | Evaluation of an interdisciplinary therapy algorithm in patients with prosthetic joint infections |
| Q36484891 | Failure of irrigation and débridement for early postoperative periprosthetic infection |
| Q26822261 | Functional outcomes of acutely infected knee arthroplasty: a comparison of different surgical treatment options |
| Q37365232 | Good results in postoperative and hematogenous deep infections of 89 stable total hip and knee replacements with retention of prosthesis and local antibiotics |
| Q39698387 | Gram-negative prosthetic joint infections managed according to a multidisciplinary standardized approach: risk factors for failure and outcome with and without fluoroquinolones |
| Q88118731 | Hydrogen Peroxide Wound Irrigation in Orthopaedic Surgery |
| Q28071834 | Implant retention after acute and hematogenous periprosthetic hip and knee infections: Whom, when and how? |
| Q40772358 | Importance of selection and duration of antibiotic regimen in prosthetic joint infections treated with debridement and implant retention. |
| Q43134051 | In vitro antimicrobial synergy testing of coagulase-negative staphylococci isolated from prosthetic joint infections using Etest and with a focus on rifampicin and linezolid |
| Q89033708 | Increased antibiotic duration improves reoperation free survival after total hip arthroplasty irrigation and debridement |
| Q89557800 | Increased antibiotic duration improves survival of irrigation and debridement after revision total joint arthroplasty |
| Q39135819 | Increased risk of joint failure in hip prostheses infected with Staphylococcus aureus treated with debridement, antibiotics and implant retention compared to Streptococcus |
| Q88993321 | Indications and Guidelines for Debridement and Implant Retention for Periprosthetic Hip and Knee Infection |
| Q91867951 | Infected primary knee arthroplasty: Risk factors for surgical treatment failure |
| Q35242716 | Infection control rate of irrigation and débridement for periprosthetic joint infection |
| Q36150686 | Irrigation and Debridement Before a 2-Stage Revision Total Knee Arthroplasty Does Not Increase Risk of Failure |
| Q42231216 | Irrigation and debridement. |
| Q38450497 | Is prosthesis retention effective for chronic infections in hip arthroplasties? A systematic literature review |
| Q42545717 | Lactobacillus as a rare cause of an infected total knee replacement: a case report |
| Q80501553 | Listeria infections associated with infliximab: case reports |
| Q40391738 | Management of Acute Hematogenous Infection Following Total Knee Arthroplasty: A Case Series of 11 Patients. |
| Q33613003 | Management of Resistant, Atypical and Culture-negative Periprosthetic Joint Infections after Hip and Knee Arthroplasty |
| Q51543438 | Management of the Infected Temporomandibular Joint Total Joint Prosthesis |
| Q42218505 | Measuring Outcomes: Pain and Quality of Life 48 Months After Acute Postoperative Total Knee Prosthetic Joint Infection |
| Q88405938 | Megaprosthesis of the knee in tumor and revision surgery |
| Q43239635 | Microbiology of the infected knee arthroplasty: report from the Swedish Knee Arthroplasty Register on 426 surgically revised cases |
| Q39315437 | Nanoantibiotics: a new paradigm for the treatment of surgical infection. |
| Q89172115 | New Innovations in the Treatment of PJI and Biofilms-Clinical and Preclinical Topics |
| Q40412096 | Novel porcine model of implant-associated osteomyelitis: A comprehensive analysis of local, regional, and systemic response. |
| Q37187474 | One hundred and twelve infected arthroplasties treated with 'DAIR' (debridement, antibiotics and implant retention): antibiotic duration and outcome |
| Q41254478 | Open debridement and prosthesis retention is a viable treatment option for acute periprosthetic joint infection after total knee arthroplasty |
| Q42231206 | Oral antibiotic therapy |
| Q37858380 | Osteomyelitis: an update for hospitalists |
| Q36505327 | Outcome of debridement and retention in prosthetic joint infections by methicillin-resistant staphylococci, with special reference to rifampin and fusidic acid combination therapy |
| Q47377155 | Outcome of enterococcal prosthetic joint infection: is combination systemic therapy superior to monotherapy? |
| Q37170879 | Outcome of one-stage cementless exchange for acute postoperative periprosthetic hip infection |
| Q37057488 | Pathogen-driven decision for implant retention in the management of infected total knee prostheses |
| Q38541963 | Periprosthetic joint infection |
| Q38093331 | Periprosthetic joint infection: Current concept |
| Q64093188 | Periprosthetic joint infections after total hip replacement: an algorithmic approach |
| Q37402408 | Periprosthetic knee infection: ten strategies that work |
| Q41686090 | Postoperative wound infection after posterior spinal instrumentation: analysis of long-term treatment outcomes |
| Q41126065 | Predictors of treatment outcome in prosthetic joint infections treated with prosthesis retention |
| Q42102366 | Preliminary results of a new antibiotic susceptibility test against biofilm installation in device-associated infections: the Antibiofilmogram®. |
| Q33956429 | Prior use of antimicrobial therapy is a risk factor for culture-negative prosthetic joint infection |
| Q38217202 | Pristinamycin: old drug, new tricks? |
| Q39367796 | Prolonged suppressive antibiotic therapy for prosthetic joint infection in the elderly: a national multicentre cohort study. |
| Q88779847 | Prosthetic Joint Infections: an Update |
| Q85174157 | Prosthetic hip infection in patients with liver cirrhosis: an outcome analysis |
| Q87601050 | Prosthetic joint infection |
| Q31131566 | Prosthetic joint infection in patients with rheumatoid arthritis: an outcome analysis compared with controls |
| Q37929757 | Prosthetic joint infection: diagnosis and management |
| Q37158397 | Prosthetic joint-associated infections treated with DAIR (debridement, antibiotics, irrigation, and retention): analysis of risk factors and local antibiotic carriers in 91 patients |
| Q88118694 | Pseudomonas Prosthetic Joint Infections: A Review of 102 Episodes |
| Q92263503 | Rates of periprosthetic infection and surgical revision in Beijing (China) between 2014 and 2016: a retrospective multicenter cross-sectional study |
| Q35652940 | Reinfection after two-stage revision for periprosthetic infection of total knee arthroplasty |
| Q40533488 | Retention of the well-fixed implant in the single-stage exchange for chronic infected total hip arthroplasty: an average of five years of follow-up |
| Q35851188 | Retention treatment after periprosthetic total hip arthroplasty infection |
| Q43233889 | Risk factors for treatment failure in orthopedic device-related methicillin-resistant Staphylococcus aureus infection. |
| Q38480446 | Risk factors for treatment failure in patients with prosthetic joint infections |
| Q64229474 | Shoulder Joint Infections with Negative Culture Results: Clinical Characteristics and Treatment Outcomes |
| Q47616780 | Single-dose bone pharmacokinetics of vancomycin in a porcine implant-associated osteomyelitis model |
| Q35624399 | Surgical procedures in the treatment of 784 infected THAs reported to the Norwegian Arthroplasty Register |
| Q37151234 | Surgical site infections in older adults: epidemiology and management strategies |
| Q35143871 | Suture-related pseudoinfection after total hip arthroplasty |
| Q36643154 | TREATMENT OF INFECTION AFTER TOTAL KNEE ARTHROPLASTY |
| Q36181397 | Teicoplanin-based antimicrobial therapy in Staphylococcus aureus bone and joint infection: tolerance, efficacy and experience with subcutaneous administration. |
| Q47368393 | Tertiary care centre adherence to unified guidelines for management of periprosthetic joint infections: a gap analysis. |
| Q64246422 | The Benefice of Mobile Parts' Exchange in the Management of Infected Total Joint Arthroplasties with Prosthesis Retention (DAIR Procedure) |
| Q34434912 | The Chitranjan Ranawat Award: fate of two-stage reimplantation after failed irrigation and débridement for periprosthetic knee infection. |
| Q37579464 | The DAIR (debridement, antibiotics and implant retention) procedure for infected total knee replacement - a literature review |
| Q91998969 | The Different Microbial Etiology of Prosthetic Joint Infections according to Route of Acquisition and Time after Prosthesis Implantation, Including the Role of Multidrug-Resistant Organisms |
| Q47597079 | The Kidney, Liver, Index surgery and C reactive protein score is a predictor of treatment response in acute prosthetic joint infection. |
| Q58214243 | The Not-So-Good Prognosis of Streptococcal Periprosthetic Joint Infection Managed by Implant Retention: The Results of a Large Multicenter Study |
| Q38122083 | The assessment of neutrophil CD64 count as an early warning marker of joint replacement infection |
| Q91344354 | The cost of managing complex surgical site infections following primary hip and knee arthroplasty: A population-based cohort study in Alberta, Canada |
| Q37793715 | The diagnosis and management of prosthetic joint infections |
| Q27000584 | The expanding horizon of prosthetic joint infections |
| Q51053996 | The management and outcome of spinal implant infections: contemporary retrospective cohort study. |
| Q40721626 | The outcome of infected total knee arthroplasty: culture-positive versus culture-negative |
| Q54411380 | The role of isolated polyethylene exchange in total knee arthroplasty. |
| Q27021270 | The role of microbial biofilms in prosthetic joint infections |
| Q36649685 | Tibial tubercle osteotomy or quadriceps snip in two-stage revision for prosthetic knee infection? A randomized prospective study |
| Q38975821 | Treatment of early postoperative infections after THA: a decision analysis |
| Q43649543 | Treatment of joint prosthesis infection in accordance with current recommendations improves outcome |
| Q58405400 | Treatment recommendations and strategies for the management of bone and joint infections |
| Q37487775 | Treatment results with debridement and retention of infected hip prostheses |
| Q35691342 | Two-Stage Total Knee Arthroplasty for Prosthetic Joint Infection |
| Q40804514 | Validation of the Charlson comorbidity index in patients undergoing revision total hip arthroplasty |
| Q37263918 | Vancomycin-rifampin combination therapy has enhanced efficacy against an experimental Staphylococcus aureus prosthetic joint infection |
| Q40198897 | Viable bacteria persist on antibiotic spacers following two-stage revision for periprosthetic joint infection |
| Q84036341 | [Early-onset infection after hemiarthroplasty of the hip: an algorithm for surgical therapy] |
| Q82647481 | [Revision arthroplasty of the elbow] |
| Q64982352 | [Treatment of septic arthritis of the shoulder and periprosthetic shoulder infections. Special problems in rheumatoid arthritis]. |